Pakistan Pharmaceuticals & Healthcare Report Q1 2015

Nov 7, 2014 - Business Monitor International - 115 pages - USD $1,295
Abstract Table of Contents Request Details Related
Pakistan holds great potential for pharmaceutical and healthcare companies, with the world's sixth largest population. However, poor medical infrastructure, low per capita incomes and the high levels of counterfeit medicines prevent the market from realising this potential. This leaves the majority of the population without access to healthcare, save for Pakistan's elite class who can afford innovative medicines.

Headline Expenditure Projections
  • Pharmaceuticals: PKR209.43bn (USD2.06bn) in 2013 to PRK231.22bn (USD2.22bn) in 2014; +10.4% in local currency terms and +7.8% in US dollar terms.
  • Healthcare: PKR717.84bn (USD7.07bn) in 2013 to PKR791.64bn (USD7.61bn) in 2014; +10.3% in local currency terms and +7.7% in US dollar terms.
Risk/Reward Index: Pakistan's Pharmaceutical Risk/Reward Index (RRI) score for Q115 is 41.7 out of 100. As a result its place in our rankings has risen to 15th, from 16th previously, out of the 19 markets in the Asia Pacific region.

Key Trends & Developments
  • In September, officials revealed that the new government has put on hold plans to restructure the financing of healthcare projects. The restructuring plan created by the former government was intended to decentralise the system in an attempt to speed up decision making.
  • In September, the Japanese government provided USD70,660 to Pakistan through the True Worth Foundation. These funds will go towards the improvement of the organisation's health centre in Chatta Bakhtawar, Islamabad. Estimates suggest that approximately 5,400 people from the outskirts of Islamabad will benefit from this project every year.
  • In October, Pakistan recorded its 200 th new case of Polio in 2014. This is the highest transmission rate in the country for more than a dozen years, alarming health experts both locally and internationally. Pakistan now accounts for 80% of the global cases of Polio and is at risk of exporting the disease out of the country.
BMI Economic...


Order This Report
FORMAT: PDF - Download Now with 3 Quarterly Updates $1,295 USD
LICENSE: Single-User
DELIVERY: Instant Download

EASY ORDERING
Once you’ve found the right report, click ‘order now’ and complete the checkout process using any major credit card, check or wire/bank transfer.

Need multi-user or enterprise license pricing? Contact us for a custom quote!
MC, Visa, AMEX, Diners, Discovery, JCB

The Fast Market Research Advantage
Only the Best
All of our research is sourced from the most trusted and established global analysts and consultancies

Client Focused
From start-ups to multinationals, we focus on providing the right research to our diverse client base

Shop Securely
Our US-based customer service team and eCommerce systems adhere to highest data security standards

Industry-leading Customer Support
Individualized assistance from our expert staff is never more than an email or phone call away


About the Publisher
Business Monitor International (BMI) offers a comprehensive range of products and services designed to help senior executives, analysts and researchers assess and better manage operating risks, and exploit business opportunities, across 175 markets. BMI offers three main areas of expertise: Country Risk BMI's country risk and macroeconomic forecast portfolio includes weekly financial market reports, monthly regional Monitors, and in-depth quarterly Business Forecast Reports. Industry Analysis BMI covers a total of 17 industry verticals through a portfolio of services, including Daily Alerts, monthly regional Insights, and in-depth quarterly Country Forecast Reports.